Dyslipidemia is a disorder of fat, or lipid, metabolism in the blood. Most often it means elevated low-density lipoprotein, or LDL cholesterol, elevated triglycerides, or several unfavorable lipid changes at the same time.
High cholesterol is usually not felt. A person may feel well even while atherosclerosis gradually develops in the blood vessels over many years. That is why the most important step is not to wait for symptoms, but to check lipid levels in time, understand overall cardiovascular disease risk and agree on further action with a doctor.
One elevated laboratory result does not tell the whole story. The doctor assesses not only cholesterol, but also age, blood pressure, smoking, diabetes, kidney function, body weight, family history and whether the person has already had a heart attack, stroke or another vascular disease.
Cholesterol and triglycerides are fats that the body needs. Cholesterol is involved in the formation of cell membranes, hormones, bile acids and vitamin D, while triglycerides serve as an energy reserve.
Because fats do not dissolve in blood, they are carried in special particles called lipoproteins. Health risk increases when too many lipoprotein particles that can enter artery walls and promote atherosclerosis circulate in the blood for a long time.
Dyslipidemia may include:
Not exactly. High cholesterol is one manifestation of dyslipidemia, but dyslipidemia is a broader term.
For example, a person may have:
Therefore, total cholesterol alone cannot fully describe a person’s cardiovascular disease risk.

Total cholesterol shows the combined amount of cholesterol in different lipoprotein particles. It is a useful initial marker, but by itself it is not enough to determine risk or the need for treatment.
Low-density lipoprotein, or LDL cholesterol, is often called “bad cholesterol” in everyday language. More precisely, a persistently elevated number of LDL particles promotes the development of atherosclerosis.
LDL particles can enter the walls of arteries, where they trigger an inflammatory reaction and participate in the formation of atherosclerotic plaques. Therefore, LDL cholesterol is the main treatment target for most patients.
High-density lipoprotein, or HDL cholesterol, is often called “good cholesterol”. HDL particles are involved in cholesterol transport and have several protective functions.
However, very high HDL levels do not automatically protect against heart disease and do not cancel out the risk caused by elevated LDL, smoking, diabetes or high blood pressure. The goal of treatment is usually not to artificially raise HDL, but to reduce the number of atherogenic particles and overall risk.
Triglycerides are fats that the body uses to store energy. Their level may increase because of:
Markedly elevated triglycerides can increase not only cardiovascular disease risk, but also the risk of acute pancreatitis.
Non-HDL cholesterol is calculated by subtracting HDL cholesterol from total cholesterol. It includes cholesterol in the main particles that contribute to atherosclerosis.
This marker may be especially useful when triglycerides are elevated, or in diabetes, metabolic syndrome or abdominal obesity.
ApoB is a protein found on the main atherogenic lipoprotein particles. In simple terms, ApoB helps assess not only the amount of cholesterol, but also the number of particles that may be harmful to blood vessels.
ApoB may be especially useful when a person has:
ApoB does not have to be measured in every patient. The doctor decides whether the test is needed.
Lp(a) is an LDL-like particle whose level is mainly determined by heredity. Elevated Lp(a) may increase the risk of atherosclerotic cardiovascular disease and aortic valve stenosis even when other cholesterol results are not very high.
Lp(a) is particularly useful to measure if:
It is usually enough to measure Lp(a) once in adult life, because it is mostly genetically determined. A level above approximately 50 mg/dl or 105 nmol/l may be used as an additional risk factor. These units cannot be precisely converted into each other, so the result should be interpreted in the units reported by the laboratory.
Remnant cholesterol is found in the remaining particles of triglyceride-rich lipoproteins. Its amount often increases together with triglycerides, insulin resistance, obesity and type 2 diabetes.
High cholesterol is not only the result of an unhealthy diet. The body produces a large part of its cholesterol itself, mainly in the liver.
Dyslipidemia may be promoted by:
Even a slim, physically active person who eats well can have high LDL or Lp(a), especially because of genetic factors.
Primary dyslipidemia is mainly caused by inherited genetic characteristics. It may be related to one specific gene change or the combined effect of many genes.
Inherited dyslipidemia should be considered if:
Secondary dyslipidemia is caused by another disease, medication or lifestyle factors.
Common possible causes include:
Finding and treating the secondary cause can significantly improve lipid results.
Familial hypercholesterolemia is an inherited condition in which LDL cholesterol is markedly elevated from childhood. If untreated, it can cause atherosclerosis and heart disease much earlier than in people without this condition.
Familial hypercholesterolemia should be considered if:
If familial hypercholesterolemia is found in one person, it is recommended to test their parents, children, brothers and sisters as well.
Most often it does not. High cholesterol usually cannot be felt, and a person may feel well even while atherosclerosis develops over many years.
Headache, dizziness and fatigue are not specific signs of high cholesterol. Other possible causes should also be looked for if these symptoms occur.
In rare cases, especially in pronounced inherited dyslipidemia, the following may appear:
Xanthelasmas may also occur in a person with normal cholesterol, so they do not by themselves confirm dyslipidemia.
It is especially important to assess cholesterol and overall cardiovascular disease risk if:
An elevated result is not a reason to panic, but it should not be ignored either.
Do not assess only total cholesterol. It is important to see LDL, HDL and triglycerides, and in some situations also non-HDL cholesterol, ApoB or Lp(a).
The doctor will help determine whether the test should be repeated, what the possible causes of the elevation may be and what your overall cardiovascular disease risk is.
It is important to know:
The same LDL cholesterol number may be acceptable for one person but too high for another. The target depends on overall risk.
Improve your diet, increase physical activity, stop smoking, control blood pressure and manage body weight.
If the doctor has prescribed medication, it should be taken regularly. Treatment should not be stopped just because the next tests have improved.
After lifestyle or medication changes, the lipid profile is usually repeated at the time set by the doctor, often after several weeks.
In many cases, a lipid profile can also be measured when the person is not fasting. This is sufficient for general risk screening.
The doctor may recommend a fasting test if:
If the laboratory has asked you to come fasting, water is usually allowed. Coffee, milk, sugar, sweetened drinks and alcohol should not be used before the test.
Not always. The result may be affected by:
If treatment does not need to be started immediately, the doctor may recommend repeating the test.
Depending on the situation, it may be necessary to check:
This does not mean that every patient needs every possible test. The doctor chooses them according to the person’s health status and risk factors.
The laboratory reference range shows what values are usually found in a certain group of people. It does not always show what level is optimal for cardiovascular disease prevention in a specific patient.
For example, LDL cholesterol that the laboratory does not mark as very high may still be too high for a person:
Therefore, treatment targets are determined by overall risk, not only by the laboratory printout.
European guidelines set LDL targets according to a person’s cardiovascular disease risk.
| Cardiovascular risk | Indicative LDL cholesterol target |
|---|---|
| Low | Below 3.0 mmol/l |
| Moderate | Below 2.6 mmol/l |
| High | Below 1.8 mmol/l and at least 50% lower than baseline |
| Very high | Below 1.4 mmol/l and at least 50% lower than baseline |
In some patients with recurrent cardiovascular events, an even lower target may be considered.
This table is not intended for self-diagnosis or independent medication dose changes. The individual risk group and target are determined by a doctor.

Cardiovascular risk is the probability of having a heart attack, stroke or another cardiovascular event over a defined period of time.
The doctor takes into account:
The same LDL cholesterol level is not equally dangerous for everyone. For example, a person who smokes and has diabetes and high blood pressure has a much higher risk than a young person without other risk factors.
SCORE2 is a European risk calculation that helps estimate the chance of having a fatal or non-fatal cardiovascular event in the next ten years.
SCORE2-OP is adapted for older people.
These calculations are mainly used for people who have not yet been diagnosed with cardiovascular disease. In a person after a heart attack, stroke or with certain high-risk conditions, risk may already be considered high or very high without using a calculator.
A risk calculator cannot replace a doctor’s consultation. It does not take into account all possible health and genetic characteristics.
These factors are not the person’s fault. Knowing about them allows earlier testing and prevention.
Even if genetic predisposition cannot be changed, overall risk can be significantly reduced by controlling other factors.

Atherosclerosis is a long-term process in which cholesterol-containing particles, inflammatory cells and connective tissue accumulate in artery walls.
The process can be shown simply as follows:
elevated LDL and other atherogenic particles → particles entering the artery wall → inflammation → formation of an atherosclerotic plaque → plaque growth or rupture → blood clot → heart attack, stroke or another acute circulatory disorder.

Atherosclerosis usually develops over many years, and during this period a person may have no symptoms.
An acute event can occur suddenly if an atherosclerotic plaque ruptures and a blood clot forms on it.
The coronary arteries supply the heart muscle with blood. If atherosclerosis narrows them, pressing or squeezing chest pain, known as angina, may occur during exertion.
If a blood clot suddenly blocks an artery, part of the heart muscle no longer receives enough oxygen and a myocardial infarction may develop.
Elevated LDL is not the only risk factor for myocardial infarction. Smoking, hypertension, diabetes, kidney disease, genetics and elevated Lp(a) also significantly increase risk.
Dyslipidemia is especially associated with ischemic stroke, which is caused by blockage of a blood vessel in the brain.
Atherosclerosis may develop in:
Not every stroke is caused by cholesterol. Stroke can also be caused by heart rhythm disorders, small vessel disease, rupture of a blood vessel and other causes.
Atherosclerosis can also affect the arteries of the legs. Peripheral artery disease may be suggested by:
Peripheral artery disease means an increased risk of atherosclerosis in other arteries of the body as well.
No. Dyslipidemia is not an infection, so immunity to it does not develop.
In some people atherosclerosis develops more slowly than in others, but this does not mean that very high LDL is harmless. The higher the level of atherogenic particles and the longer it persists, the greater the lifetime accumulated risk may be.
Not smoking, normal blood pressure, physical activity and good diabetes control reduce risk, but they do not completely cancel the impact of very high LDL or Lp(a).
In diabetes, the lipid profile may be unfavorable even when LDL cholesterol is not very high.
Common findings include:
Diabetes affects blood vessels in other ways as well, so cholesterol targets for patients with diabetes are often lower than for people without diabetes.
Metabolic syndrome is a set of interconnected risk factors that may include:
These changes are often linked to insulin resistance and increase the risk of diabetes, fatty liver and cardiovascular disease.
Body mass index does not always fully describe how fat is distributed in the body. Fat accumulation around the abdomen is closely linked to:
Even a person with an apparently normal weight may have an increased waist circumference and elevated cardiometabolic risk.
Metabolic dysfunction-associated steatotic liver disease, or MASLD, is often seen together with:
Fatty liver by itself usually does not mean that cholesterol-lowering medicines cannot be used. If statins are needed to reduce cardiovascular disease risk, the doctor assesses liver status and laboratory results.
The goal of treatment is not only to improve laboratory results. The main aim is to reduce:
Treatment may include:
Lifestyle change may be the main initial approach if:
After a defined period, tests are repeated and the result is assessed.
In high- and very-high-risk patients, lifestyle changes are necessary, but they usually do not replace medication.
Cholesterol-lowering medicines are more often needed if:
The decision to use medicines is made by the doctor together with the patient, explaining the expected benefits and possible risks.
Statins are the most widely studied group of cholesterol-lowering medicines. They reduce cholesterol production in the liver and help the liver remove LDL particles from the blood more effectively.
Statins reduce not only LDL cholesterol, but also the risk of myocardial infarction and stroke. They are first-line medicines when drug treatment is needed after assessment of overall risk.
The specific medicine and dose are chosen by the doctor.
For many people, dyslipidemia and atherosclerotic risk are long-term. When statins are stopped, LDL cholesterol usually returns to the previous level.
Therefore, in high-risk patients treatment is often needed long term or lifelong. This does not mean that the medicines are addictive. They control a metabolic process but do not remove inherited or long-standing predisposition.
If LDL has reached the target while taking medication, this usually means that the treatment is working. After treatment is stopped, cholesterol levels most often rise again.
The dose or use of medicines may be changed only after consultation with a doctor.
Some patients experience muscle pain, tenderness or weakness while taking statins. However, muscle pain is common for many other reasons as well.
If such symptoms occur, treatment should not be stopped without medical advice. The doctor may:
Severe muscle injury is a very rare complication.
Serious statin-related liver injury is very rare. Before treatment, the doctor usually checks liver markers, while further tests are performed as needed.
A mild increase in liver enzymes does not always mean dangerous liver damage. The results are assessed by the doctor.
Fatty liver is usually not a reason to automatically avoid statin treatment.
Statins may slightly increase the likelihood of developing type 2 diabetes, mainly in people who already have prediabetes, obesity or insulin resistance.
In patients with high cardiovascular risk, the benefit of preventing heart attack and stroke usually clearly outweighs this small additional risk. If needed, the doctor monitors glucose levels regularly.
Complete statin intolerance is less common than it may first seem.
The doctor may check:
Even a small tolerated statin dose combined with another therapy may provide meaningful benefit.
If a statin is not tolerated or is not enough, the doctor may choose other groups of medicines that:
Sometimes the best result can be achieved with a combination of several medicine groups. The specific therapy is chosen by the doctor, taking into account the required LDL reduction, coexisting diseases, tolerability and possible interactions with other medicines.
First, the possible cause is assessed:
Treatment may include dietary change, weight reduction, stopping or limiting alcohol, improving diabetes control and, in some cases, medicines.
If triglycerides are very high, the priority of treatment may be prevention of acute pancreatitis.
A heart-healthy diet is based on:
It is recommended to reduce:
It is important not only to exclude something, but also to choose a healthier replacement. Saturated fats are better replaced with unsaturated fats, whole grains and fibre, not with sugar or refined carbohydrates.
This dietary pattern includes:
Such a diet may help reduce overall cardiovascular disease risk and improve body weight, blood pressure, glucose metabolism and triglyceride levels.
When LDL is very high for genetic reasons, dietary change alone is usually not enough.
For most people, eggs do not have to be completely excluded. The effect of dietary cholesterol on LDL differs from person to person.
The overall dietary pattern, saturated fat intake, body weight, genetics and coexisting diseases are usually more important than one single food.
People with familial hypercholesterolemia or already diagnosed heart disease should discuss an individual nutrition plan with a doctor or nutrition specialist.
Butter contains a lot of saturated fat, which may raise LDL cholesterol in some people.
In everyday eating, part of butter and other animal fats should preferably be replaced with sources of unsaturated fats, such as plant oils, nuts, seeds and fish.
Soluble fibre can help reduce LDL cholesterol by reducing the reabsorption of cholesterol and bile acids in the intestine.
Good sources of fibre include:
Fibre intake should be increased gradually while drinking enough fluids.
Ordinary fish oil supplements are not a treatment for LDL cholesterol and cannot replace statins.
Some omega-3 preparations can reduce triglycerides, but the composition and evidence differ between products. In certain situations, a doctor may prescribe therapy with a specific active ingredient, but this should not be equated with ordinary fish oil.
Dietary supplements cannot replace doctor-prescribed cholesterol-lowering therapy when it is needed to reduce cardiovascular disease risk.
Red yeast rice products may contain substances with statin-like effects. The amount of active ingredient, quality and impurities may vary, while side effects and interactions with other medicines may be similar to statins.
Before using any dietary supplement, a doctor or pharmacist should be consulted.
There is no drink, dietary supplement or short-term cleanse that washes cholesterol out of the arteries.
Reducing atherosclerosis risk is a long-term process:
Effective treatment can stabilize atherosclerotic plaques and reduce the risk of acute heart attack or stroke, but it is not accurate to call this “cleaning” the blood vessels.
Adults are advised to do at least 150-300 minutes of moderate-intensity aerobic activity per week or 75-150 minutes of vigorous-intensity activity. Muscle-strengthening exercises are also desirable at least two days per week.
During moderate-intensity activity, breathing becomes faster, but the person is still able to talk. This may include brisk walking, cycling, swimming or another suitable activity.
Regular physical activity can:
Regular walking is also valuable. If the previous lifestyle was sedentary, exercise should be increased gradually.
If a person is overweight, even moderate and sustained weight reduction can:
If LDL is mainly elevated for genetic reasons, weight loss alone may not normalize it.
Smoking significantly increases cardiovascular disease risk regardless of cholesterol level.
It damages the inner layer of blood vessels, promotes inflammation, clot formation and instability of atherosclerotic plaques.
Stopping smoking is one of the most important steps in reducing heart attack and stroke risk.
Alcohol is not recommended as a way to raise HDL cholesterol or prevent heart disease.
It can:
When triglycerides are very high, the doctor may recommend not drinking alcohol at all.
Insufficient sleep and long-term stress are not the only causes of high cholesterol, but they can worsen:
If there is loud snoring, pauses in breathing during sleep and marked daytime sleepiness, testing for sleep apnea should be considered.
After lifestyle or medication changes, lipid tests are often repeated after approximately 4-12 weeks.
Once the target has been reached and treatment is stable, the frequency of follow-up is determined individually. Many patients have tests once or twice a year.
More frequent monitoring may be needed:
For a more useful consultation, it is helpful to bring or prepare:
It depends on the cause.
If lipid abnormalities are caused by hypothyroidism, poorly controlled diabetes, alcohol, certain medicines or weight gain, treating the underlying cause can significantly improve test results.
In genetically determined dyslipidemia, the predisposition remains lifelong, but it can be successfully controlled and the risk of complications can be significantly reduced.
In children, dyslipidemia may be related to:
Checking cholesterol is especially important if:
A child’s assessment and treatment are managed by a pediatrician or an appropriate pediatric specialist.
During pregnancy, cholesterol and triglyceride levels rise physiologically because lipids are needed for fetal development.
For most women, these changes do not need to be treated with medication. Markedly elevated triglycerides or severe familial hypercholesterolemia should be monitored by a specialist.
A woman who is taking cholesterol-lowering medicines and is planning pregnancy should consult a doctor about therapy in good time. Medicines should not be continued, stopped or restarted without medical advice.
After menopause, LDL cholesterol may rise and fat distribution in the body may change. With age, high blood pressure, insulin resistance and other risk factors also become more common.
Hormone replacement therapy is not started solely to lower cholesterol or prevent heart disease.
Treatment decisions in older adults are not made based on age alone.
The doctor assesses:
For a healthy and active older person, cholesterol treatment can be very important, especially after a heart attack or stroke.
A planned doctor’s consultation is needed if:
The initial assessment can often be performed by a family doctor or internist. Depending on the situation, a cardiologist, endocrinologist, nephrologist, pediatrician or nutrition specialist may need to be involved.
Dyslipidemia itself usually does not cause acute symptoms. However, its complications can be life-threatening.
Emergency services should be called immediately if there is:
A heart attack may also occur without pronounced pain, especially in people with diabetes, women and older patients. Emergency help should not be delayed while trying to determine the cause of symptoms yourself.
Dyslipidemia is a lipid metabolism disorder that may include elevated LDL cholesterol, triglycerides, ApoB or Lp(a), as well as low HDL cholesterol. It usually causes no symptoms, but in the long term it can promote atherosclerosis, myocardial infarction and stroke. Treatment is determined not only by laboratory results, but by the person’s overall cardiovascular disease risk.
The information in this article is for informational and educational purposes. It does not replace a doctor’s consultation, individual diagnosis or treatment. If you have elevated cholesterol or triglycerides, diabetes, high blood pressure, obesity, kidney disease, a history of smoking, early heart disease in the family or already diagnosed cardiovascular disease, consult a doctor or the clinic specialists listed below the article. You should not diagnose yourself, stop prescribed treatment on your own or start prescription medicines without a doctor’s instructions.
| Qualification | Clients of the clinic | First visit |
|---|---|---|
| Highly qualified doctor | 85.50 € | 90 € |
| Doctor | 52.25 € | 55 € |
Nutrition Specialist Guna HavensoneAsk a question Make an appointment |
Nutrition Specialist Ksenija KukulaAsk a question Make an appointment |







